Haptoglobin phenotypes differ in their ability to inhibit heme transfer from hemoglobin to LDL.
about
Haptoglobin genotype and its role in determining heme-iron mediated vascular diseaseNatural history of the bruise: formation, elimination, and biological effects of oxidized hemoglobinPharmacogenomic interaction between the Haptoglobin genotype and vitamin E on atherosclerotic plaque progression and stability.Divergent effects of alpha-tocopherol and vitamin C on the generation of dysfunctional HDL associated with diabetes and the Hp 2-2 genotype.Heme degradation and vascular injury.The haptoglobin 2-2 genotype is associated with increased redox active hemoglobin derived iron in the atherosclerotic plaque.Haptoglobin genotype-dependent differences in macrophage lysosomal oxidative injury.Vitamin E reduces cardiovascular disease in individuals with diabetes mellitus and the haptoglobin 2-2 genotypeRedox properties of human hemoglobin in complex with fractionated dimeric and polymeric human haptoglobinThe reaction of cell-free oxyhemoglobin with nitrite under physiologically relevant conditions: Implications for nitrite-based therapies.Can gas replace protein function? CO abrogates the oxidative toxicity of myoglobinEffects of carnitine on oxidative stress response to intravenous iron administration to patients with CKD: impact of haptoglobin phenotype.HDL dysfunction in diabetes: causes and possible treatments.Pharmacogenomic application of the haptoglobin genotype in the treatment of HDL dysfunctionIs it time to screen for the haptoglobin genotype to assess the cardiovascular risk profile and vitamin E therapy responsiveness in patients with diabetes?Haptoglobin genotype and cardiovascular outcomes in diabetes mellitus - natural history of the disease and the effect of vitamin E treatment. Meta-analysis of the medical literature.Patient selection and vitamin E treatment in diabetes mellitus.Effect of vitamin E supplementation on HDL function by haptoglobin genotype in type 1 diabetes: results from the HapE randomized crossover pilot trial.Pharmacogenomics in prevention of diabetic cardiovascular disease: utilization of the haptoglobin genotype in determining benefit from vitamin E.Vitamin E in the prevention of cardiovascular disease: the importance of proper patient selection.The haptoglobin 2-2 genotype is associated with a reduced incidence of Plasmodium falciparum malaria in children on the coast of Kenya.Haptoglobin 1-1 genotype is associated with poorer cognitive functioning in the elderly with type 2 diabetes.Epistasis between the haptoglobin common variant and α+thalassemia influences risk of severe malaria in Kenyan children.Changing the face of diabetic care with haptoglobin genotype selection and vitamin e.Red blood cell, hemoglobin and heme in the progression of atherosclerosisAssociation between haptoglobin 2-2 genotype and coronary artery disease and its severity in a tunisian population.Haptoglobin Genotype-Dependent Anti-Inflammatory Signaling in CD163(+) Macrophages.Sustained treatment of sickle cell mice with haptoglobin increases HO-1 and H-ferritin expression and decreases iron deposition in the kidney without improvement in kidney function.Correction of HDL dysfunction in individuals with diabetes and the haptoglobin 2-2 genotype.Haptoglobin Genotype and Outcome after Subarachnoid Haemorrhage: New Insights from a Meta-Analysis.Haptoglobin Phenotype Among Arab Patients With Mental Disorders.Macrophage infiltration and smooth muscle cells content associated with haptoglobin genotype in human atherosclerotic carotid plaques.Comparative analysis of oxy-hemoglobin and aquomet-hemoglobin by hydrogen/deuterium exchange mass spectrometry.Haptoglobin from psoriatic patients exhibits decreased activity in binding haemoglobin and inhibiting lecithin-cholesterol acyltransferase activity.Hemoglobin as a source of iron overload in multiple sclerosis: does multiple sclerosis share risk factors with vascular disorders?
P2860
Q26852155-98EAA10F-52D6-44EB-A840-2543485A04E2Q26862163-15C300A1-A701-4A1A-BB5D-8AF294DA7EBCQ27332892-68B73F44-76D3-4DC0-BE8A-38964788D581Q33649886-D970F8C2-5E16-47E4-A2C4-2E64E5A2D60FQ33649898-1B33A804-D7EB-4DB6-8D67-56CD555F6FEDQ33695531-7C4B1AEC-3B6B-481B-918D-6EE6EB9D6C27Q33718536-66D99446-C50E-47D2-BA70-E987270A5811Q33894052-749303F0-087F-4583-8233-C55BB3C4AA8FQ33923731-1DB3EF77-5929-47DD-98FD-34F26C1478C3Q34880703-C293980E-4CAC-48BB-B51D-02AD0D873746Q35222724-FC30769D-8419-4949-987F-3DEA3EBBE9D4Q35744436-5FC104FA-A906-4608-9F24-02C4A230E034Q35904110-5DCD0EAF-F9A0-44D2-8A4A-26766E0003DFQ36441429-AAD008F8-1F9F-4D7C-823F-EEF7ECA7F8E9Q36664118-A2F3830A-FAC4-47C2-9B4A-3AA6F3B7BE73Q36691768-038F6A54-9C3E-431A-872E-6735FF10A65FQ36736431-2212D261-4BF3-4FF8-B07F-EBFA74ACFE75Q36782847-D4DAC7BD-A849-4032-89AC-5E443DF72D03Q37012941-2DCFB67A-7565-4441-BF07-64CEA5513023Q37076469-8B85719C-FEF6-4317-A896-F33D5473C39FQ37138058-D2A343B8-7E0C-4CB0-81DB-ED857276B849Q37193458-51456BC0-398B-47D6-A836-C3C9CC6A209BQ37670058-0A1482D7-C607-4DDE-B4C3-9094DF3C6FCFQ38126020-ADB2704D-EE84-4926-A3B6-E706E056AA59Q38261012-846B7B94-0E56-4659-B3B8-FE310A0A0B1CQ39276104-127E7301-30C8-4A8E-BEFE-7C407E39BDBFQ40755949-5C0275E3-9B1C-4882-867F-809BABE65E0FQ42760191-FEC4ABA1-E993-4B6B-BACF-8735FF195A0BQ42918985-2B1F03DF-F149-4E10-BDD1-E00D15382124Q45765478-ED2E40A7-9583-479D-88F1-99A1ED105D7DQ49298413-3BFFB9BB-EE01-41CA-964D-2BA13CB8C185Q50533725-4AC56CCE-08EF-4FD0-A857-8F9E248720EBQ51000092-5BFC7118-655E-4D0B-9843-AFD7E8D836B1Q54344172-5172BFB1-8784-4C45-BE41-593B1AEE5D29Q57898104-4F36C69A-DB71-4109-8D7D-F4FE7096BC92
P2860
Haptoglobin phenotypes differ in their ability to inhibit heme transfer from hemoglobin to LDL.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Haptoglobin phenotypes differ ...... ansfer from hemoglobin to LDL.
@en
Haptoglobin phenotypes differ ...... ansfer from hemoglobin to LDL.
@nl
type
label
Haptoglobin phenotypes differ ...... ansfer from hemoglobin to LDL.
@en
Haptoglobin phenotypes differ ...... ansfer from hemoglobin to LDL.
@nl
prefLabel
Haptoglobin phenotypes differ ...... ansfer from hemoglobin to LDL.
@en
Haptoglobin phenotypes differ ...... ansfer from hemoglobin to LDL.
@nl
P2093
P356
P1433
P1476
Haptoglobin phenotypes differ ...... ransfer from hemoglobin to LDL
@en
P2093
Matityahu Shaklai
Nurith Shaklai
Vladimir A Tsemakhovich
P304
P356
10.1021/BI0362626
P407
P577
2004-04-01T00:00:00Z